The US FDA has approved Pretomanid tablets in combination with bedaquiline and linezolid for the treatment of specific types of drug-resistant pulmonary tuberculosis.
The latest report from the ECDC and WHO has analysed the 2017 data for the European region, suggesting that despite an overall decline in the number of cases, TB remains a major public health challenge.
The UN High Level Meeting (UNHLM) on tuberculosis (TB) – a potential turning point to end the world’s leading infectious killer
Dr. Suvanand Sahu, Deputy Executive Director, at the Stop TB Partnership, reflects on the UNHLM on TB outlining the progress that was made and what more needs to be done.
In line with World Tuberculosis Day 2019, we are hosting a Twitter chat #TalkTB with prominent experts in the field of tuberculosis on Thursday March 21 at 11:00 EDT / 15:00 GMT.